Funder: National Institutes of Health
Due Dates (Anticipated): October 2026 (Full application deadline, projected)
Funding Amounts: Exploratory/developmental projects: up to 2 years; research projects: 4–5 years. Typical NIH award size; total funding not specified.
Summary: Supports multidisciplinary research to advance understanding of biological effects of radionuclide-emitted radiation in preclinical cancer models, aiming to improve radiopharmaceutical therapies.